nonprofit logo

The American College Of Neuropsychopharmacology Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 221736045 ✦ Brentwood, TN ✦ Designated as a 501(c)(3)

Overview

What is The American College Of Neuropsychopharmacology Inc?

The American College of Neuropsychopharmacology Inc, located in Brentwood, Tennessee, serves as a platform for advancing research and education in neuropsychopharmacology and related fields. Their primary goal is to foster collaboration among various scientific disciplines of brain and behavior to comprehensively understand, prevent, and treat neurological, psychiatric, behavioral, and addictive disorders. They encourage scientists to pursue research careers in these domains and disseminate relevant scientific breakthroughs. The organization's activities include hosting an annual meeting, publishing a journal, reviewing research through NPP Reviews, and undertaking committee and task force projects. Their 2021 annual meeting attracted 2,075 scientists, with 57% attending in person due to the ongoing COVID-19 pandemic. A majority of attendees rated the meeting as superior to others they attended.


Official website here: www.acnp.org

Is The American College Of Neuropsychopharmacology Inc legitimate?

The American College Of Neuropsychopharmacology Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. The American College Of Neuropsychopharmacology Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $223,852
Professional Fundraising Fees: $0
Other Salaries and Wages: $439,102

For more financial information, click here


Official website here: www.acnp.org

What is the mission statement of The American College Of Neuropsychopharmacology Inc?

The American College of Neuropsychopharmacology Inc's primary goal is to advance research and education in neuropsychopharmacology and related fields. They achieve this by encouraging the collaboration of various scientific disciplines focused on brain and behavior, aiming to enhance the understanding of the causes, prevention, and treatment of neurological, psychiatric, behavioral, and addictive disorders. The organization also encourages scientists to pursue careers in these fields and disseminates relevant scientific advancements in these disorders. Their activities include hosting an annual meeting, publishing a journal, and undertaking committee and task force projects.


Official website here: www.acnp.org

Who is the CEO of The American College Of Neuropsychopharmacology Inc?

Sarah Timm is the Principal Officer of The American College Of Neuropsychopharmacology Inc.


Official website here: www.acnp.org

What is the revenue of The American College Of Neuropsychopharmacology Inc?

The American College Of Neuropsychopharmacology Inc's revenue in 2022 was $3,872,941.


Official website here: www.acnp.org

Who are the executives of The American College Of Neuropsychopharmacology Inc and what are their salaries?

Here are 16 key members and their salaries:

    Sarah S Timm (Executive Director)
  • Compensation: $133,214
  • Related: $211,637
  • Other: $19,400

    • William A Carlezon (Council Member) [Trustee/Director]
  • Compensation: $38,334
  • Related: $0
  • Other: $0

    • Trevor W Robbins (Council Member) [Trustee/Director]
  • Compensation: $2,500
  • Related: $0
  • Other: $0

    • Marina E Wolf (Council Member) [Trustee/Director]
  • Compensation: $1,500
  • Related: $0
  • Other: $0

    • Linda S Brady (President (2021)) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Carlos A Zarate (President (2022)) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Rita J Valentino (Secretary) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • David R Rubinow (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Carrie E Bearden (Council Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Ellen Leibenluft (Council Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Helen S Mayberg (Council Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Maria A Oqendo (Council Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Mary L Phillips (Council Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Marina R Picciotto (Council Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Diego A Pizzagalli (Council Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Kerry J Ressler (Council Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.acnp.org

    Where can I find the form 990 for The American College Of Neuropsychopharmacology Inc?

    The The American College Of Neuropsychopharmacology Inc’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.acnp.org

    Learn more at the official website: www.acnp.org

    Mission Statement of The American College Of Neuropsychopharmacology Inc

    The American College of Neuropsychopharmacology Inc is committed to driving advancements in research and education within the field of neuropsychopharmacology and related disciplines. This organization plays a crucial role in promoting interdisciplinary collaboration between various scientific disciplines related to brain and behavior. By fostering this interaction, the American College of Neuropsychopharmacology Inc aims to deepen understanding of the causes, prevention, and treatment of a wide range of nervous system disorders, encompassing psychiatric, neurological, behavioral, and addictive disorders.

    Moreover, the American College of Neuropsychopharmacology Inc actively encourages scientists to pursue research careers in fields associated with these disorders and their treatments. This commitment to fostering the next generation of researchers is integral to the organization's mission. Lastly, the American College of Neuropsychopharmacology Inc ensures that relevant scientific advancements in these disorders are disseminated widely, thereby contributing to a greater collective understanding and potential solutions. Through its annual meeting, journal, NPP reviews, and committee & task force projects, the American College of Neuropsychopharmacology Inc plays a vital role in driving progress in neuropsychopharmacology and related fields.

    Impact

    This information is meant to be a general summary of The American College Of Neuropsychopharmacology Inc. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    The American College of Neuropsychopharmacology Inc's impact lies in its dedication to advancing research and education in neuropsychopharmacology and related fields. By promoting interdisciplinary collaboration and fostering scientific dialogue, the College contributes to the understanding, prevention, and treatment of diseases of the nervous system, including psychiatric, neurological, behavioral, and addictive disorders. Through activities such as annual meetings, publications, and committee projects, the College serves as a hub for disseminating scientific advancements and encouraging researchers to pursue careers in areas crucial to addressing these complex disorders. This impact resonates not only within the neuropsychopharmacology community but also in the broader efforts to combat disease and improve mental health outcomes.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $755,640
  • Program Service Revenue: $1,867,716
  • Gross Receipts: $5,691,491

    • Assets and Liabilities:
  • Total Assets: $21,198,783
  • Total Liabilities: $364,658
  • Net Assets: $20,834,125
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    ROYALTY INCOME

    Revenue

    $1,031,516

    MEETING REGISTRATION FEES

    Revenue

    $836,200

    Organization Details

    Founding Year

    1961

    Principal Officer

    Sarah Timm

    Main Address

    5034A THOROUGHBRED LANE, BRENTWOOD, TN, 37027

    NTEE Category

    Code: G96C - Disease

    If you are a representative of The American College Of Neuropsychopharmacology Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.